Navigation Links


VNP40101M at Biology News

VNP40101M at Biology Products
VNP40101M at Biology Technology
VNP40101M at Medicine News
VNP40101M at Medicine Products
VNP40101M at Medicine Technology

Vion Pharmaceuticals Presents Clinical Data from a Phase II Trial of Cloretazine (VNP40101M) in Elderly AML Patients with Unfavorable Cytogenetics at EHA Meeting

NEW HAVEN, Conn., June 11, 2007 /PRNewswire-FirstCall/ -- VionPharmaceuticals, Inc. announced that it presented clinical data ina poster session at the 12th Congress of the European HematologyAssociation (EHA) Meeting in Vienna, Austria on its lead anticanceragent Cloretazine(R) (VNP40101M) as a single agent in amulti-center international Phase II clinical trial in a subset ofelderly pat...

Vion Pharmaceuticals Presents Updated Clinical Data from a Phase II trial of Cloretazine (VNP40101M) in Patients with Relapsed or Refractory Small Cell Lung Cancer

NEW HAVEN, Conn., June 04, 2007 /PRNewswire-FirstCall/ -- VIONPHARMACEUTICALS, INC. announced that it presented updated clinicaldata in a poster session at the 43rd Annual Meeting of The AmericanSociety of Clinical Oncology (ASCO) on its lead anticancer agentCloretazine(R) (VNP40101M) as a single agent in a Phase II trial inpatients with relapsed or refractory small cell lung cancer....

Vion Presents Data on Cloretazine (VNP40101M) at the 100th Annual Meeting of the American Association of Cancer Research (AACR)

NEW HAVEN, Conn., April 13, 2007 /PRNewswire-FirstCall/ -- VIONPHARMACEUTICALS, INC. announced today that data on its leadanticancer agent Cloretazine(R) (VNP40101M) will be presented inposters at the 100th Annual Meeting of the American Association ofCancer Research in Los Angeles, California. All three posters willbe available on Vion's website, <a target="_blank" href="http://www.vion...
Other TagsAspAspAspAspAspDiodePico
(Date:12/2/2008)...etter spent in other areas, experts say , ...apid response teams, created to prevent cardiac ar... seem to work, a new study finds. , "Many hospi...cade," said lead researcher Dr. Paul S. Chan, a ca...ansas City, Mo. "Earlier studies had shown that ra...
(Date:12/2/2008)...ost were as effective, despite editorials urging o... News) -- Brand-name drugs used to treat cardiovas...eview of available evidence shows. , Yet a numb...pecialists, have urged against substituting the le...rts. , "We found no evidence that brand-name dr...
(Date:12/2/2008)... The latest development in the standard...nd electronic health record systems was announced ...eeting of the Radiological Society of North Americ...th Story Project (previously known as the CDA for ... CHICAGO (Business Wire EON) D...
(Date:12/2/2008)...ialists from the USC Viterbi School of Engineering...imes for operating rooms at three California safet...ime surgery per year." Because of the success of t...hree more hospitals. , A team from the Viterbi S...ms Engineering began work in January, 2008 at Chil...
Breaking Medicine News(10 mins):Health News:Rapid Response Teams Don't Cut Hospital Heart Attacks, Death Rates 2Health News:Rapid Response Teams Don't Cut Hospital Heart Attacks, Death Rates 3Health News:Generic Heart Drugs as Good as Brand-Name Counterparts 2Health News:Generic Heart Drugs as Good as Brand-Name Counterparts 3Health News: Health Level Seven and The Health Story Project Announce Publication of Diagnostic Imaging Report Guide at Annual RSNA Meeting : HL7 Clinical Document Architecture (CDA) Implementation Guide Enhances Radiology Reporting 2Health News: Health Level Seven and The Health Story Project Announce Publication of Diagnostic Imaging Report Guide at Annual RSNA Meeting : HL7 Clinical Document Architecture (CDA) Implementation Guide Enhances Radiology Reporting 3Health News: Health Level Seven and The Health Story Project Announce Publication of Diagnostic Imaging Report Guide at Annual RSNA Meeting : HL7 Clinical Document Architecture (CDA) Implementation Guide Enhances Radiology Reporting 4Health News: Health Level Seven and The Health Story Project Announce Publication of Diagnostic Imaging Report Guide at Annual RSNA Meeting : HL7 Clinical Document Architecture (CDA) Implementation Guide Enhances Radiology Reporting 5Health News:Operations engineering for more efficient operating rooms 2Health News:Operations engineering for more efficient operating rooms 3
(Date:12/2/2008)...er is delighted to announce that starting in Janua...quarterly peer-reviewed journal Energy for Sustai... on behalf of the International Energy Initiative ...ing present human needs without compromising needs...ding many of these needs - food, warmth, light, tr...
(Date:12/2/2008)...trition related topics raises unique challenges no... new article, a team of researchers use specific e...tations of systematic reviews relevant to nutritio... , Systematic reviews, also referred to as evid...with pre-specified questions that can be used to d...
(Date:12/2/2008)...Presbycusis, or age-related hearing loss, accounts...ome people lose their hearing as they get older bu...e answer may be in a study released online in the ... is available online at http://hmg.oxfordjournals...ver and largest genome-wide association study for ...
(Date:12/1/2008)...g widespread consumption advisories and uncertaint...at. Now researchers at North Carolina State Univer...sts and regulators around the country predict whic...levels a breakthrough that should help officials ...visories for specific water bodies and fish specie...
Breaking Biology News(10 mins):New publishing partnership for Energy for Sustainable Development 2Experts discuss applying systematic review to the field of nutrition 2House Ear Institute, TGen and Belgian researchers identify gene in age-related hearing loss 2New model predicts hot spots for mercury in fish 2Genencor Launches First Ever Commercial Enzyme Product for Cellulosic Ethanol 1263 1Genencor Launches First Ever Commercial Enzyme Product for Cellulosic Ethanol 1263 2Genencor Launches First Ever Commercial Enzyme Product for Cellulosic Ethanol 1263 3Knopp Neurosciences Receives Orphan Designation for KNS 760704 for Treatment of ALS 514 1Knopp Neurosciences Receives Orphan Designation for KNS 760704 for Treatment of ALS 514 2Many Patients Dont Report Use of OTC Pain Drugs 3674 1Many Patients Dont Report Use of OTC Pain Drugs 3674 2Many Patients Dont Report Use of OTC Pain Drugs 3674 3Older African American men with HIV often have sex without condoms 3672 1Older African American men with HIV often have sex without condoms 3672 2
Other Contentsnocturnalnocturnalnocturnalnocturnalnocturianitnoninvasivenoninvasivenoninvasivenoninvasivenoninvasivenoninvasivedrugsdrugsdrugsdrugsdrugsdrugsdrugsdrugsdrugsdrugsnonsteroidalnonsteroidalnonunion